Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

1699274

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Physician Associates
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government, further to the Written Answer by Lord Markham on 25 March (HL2978), why they have specified how physician associates (PAs) are to be used, specifically with undifferentiated patients, rather than allowing GP practices to make their own decisions about the use of PAs.
	tabling member printed	Baroness Bennett of Manor Castle
	uin	HL3652
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>Physician Associates (PAs) work within a defined scope of practice and limits of competence. NHS England has provided recent guidance on the use of PAs in general practice (GP) teams. As set out in the Network Contract Directed Enhanced Service, PAs should be adequately supervised by a GP when providing care for undifferentiated patients.</p><p>In terms of employment choices, GPs are self-employed contractors to the National Health Service, and it is largely up to employers to determine how best to staff their primary care network or GP, to best meet the needs of their population.</p> answering member printed Lord Markham question first answered 05/04/2024 13:32:33 answering member 4948 label Biography information for Lord Markham
	tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

1699315

	registered interest
	date	27/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made, in each of the past five years, of the economic costs of the effects of post-operative cancer treatments.
	tabling member printed	Lord Wills
	uin	HL3712
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The Department is working jointly with NHS England and Cancer Alliances to ensure every person receives personalised care and support from cancer diagnosis onwards, including post-treatment. As outlined in the NHS Long Term Plan for cancer, where appropriate, every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support. After treatment, the person will move to a follow-up pathway that suits their needs, and ensures they can get rapid access to clinical support, where they are worried that their cancer may have recurred.</p><p>Post-operative cancer treatments encompass a wide variety of care, depending on the type and stage of cancer, the treatment the patient has had, and the patient’s needs. Follow-up care often includes regular check-ups, blood tests, scans, and procedures. It may also involve further treatments to deal with late and long-term side effects, including chemotherapy or radiotherapy to reduce the risk of cancer coming back. These highly individualised treatments have varying economic costs.</p> answering member printed Lord Markham question first answered 05/04/2024 13:26:44 answering member 4948 label Biography information for Lord Markham
	tabling member	260 label Biography information for Lord Wills

1699250

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Plastic Surgery: Public Consultation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government when they intend to publish feedback to the Licensing of non-surgical cosmetic procedures consultation, which ran from 2 September to 28 October 2023.
	tabling member printed	The Lord Bishop of St Albans
	uin	HL3640
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>We are currently analysing the feedback received during the consultation, and intend to publish the Government’s response later in the spring.</p> answering member printed Lord Markham question first answered 05/04/2024 13:10:18 answering member 4948 label Biography information for Lord Markham
	tabling member	4308 label Biography information for The Lord Bishop of St Albans

1698269

	registered interest
	date	25/03/2024
	answering body	Department for Environment, Food and Rural Affairs
	answering dept id	13
	answering dept short name	Environment, Food and Rural Affairs
	answering dept sort name	Environment, Food and Rural Affairs
	hansard heading	Bridleways and Public Footpaths: Motor Vehicles
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made, if any, of the scale of damage to public footpaths and bridleways caused by four-wheel drive vehicles and scrambler bikes.
	tabling member printed	Lord Birt
	uin	HL3573
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The recreational use of motor vehicles on footpaths, bridleways and restricted byways is not permitted, therefore no such assessment has been undertaken. Any damage caused by illegal activity is a matter for the appropriate authorities.</p><p> </p><p>The Government is aware of damage and disturbance caused by excessive use of off-road motor vehicles on highways where such activities are legal, such as byways open to all traffic and on other unsealed roads which carry motor vehicle rights, often referred to as ‘green lanes’. This issue was included in the consultation on the recent Landscapes Review. The results of the consultation concluded that the current Traffic Regulation Order process is legally robust enough to protect green lanes with targeted local action in sensitive areas, while allowing vehicle users to responsibly enjoy the countryside.</p> answering member printed Lord Benyon question first answered 05/04/2024 10:57:11 answering member 1547 label Biography information for Lord Benyon
	tabling member	2533 label Biography information for Lord Birt

1698279

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Databases
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government further to the Written Answers by Lord Markham on 27 February 2023 (HL5458) and 14 March 2023 (HL5916), whether they will place in the Library of the House a copy of the YAML, R and Python code exportable from NHS England's Federated Data Platform for (1) the Ambulance Dataset Dashboard, and (2) the COVID Monitoring Reporting and Publication Dashboard.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL3583
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>NHS England will from time to time publish examples of code and specifications that are deemed useful to the wider community and industry, including where appropriate, the sharing of code within the NHS GitHub.</p><p> </p><p>To ensure that NHS England is creating a vibrant marketplace for both end users and for industry, it aims to publish the Canonical Data Model structures as well as the metadata, in line with the Tech Code of Practice.</p><p> </p><p>The Federated Data Platform (FDP) Programme is developing a sustainable way to publish examples of specifications and code for specific FDP products. The programme is working through a set of core principles to help determine how they will publish analysis code publicly. This includes making sure that there is appropriate explanatory information surrounding the code, that will help to provide additional context for those viewing the information.</p> answering member printed Lord Markham question first answered 05/04/2024 13:33:02 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1698293

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what steps they are taking to adopt a new immunisation programme and ensure that there is high uptake of this programme.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL3597
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The Department is advised by the independent Joint Committee on Vaccination and Immunisation (JCVI). The JCVI considers the disease’s burden on society, vaccine safety and efficacy, and the impact and cost effectiveness of immunisation strategies, before making a recommendation as to whether a new immunisation programme should be developed. This advice is then considered by the Department and, subject to that consideration, the Department works with partners, including the National Health Service and the UK Health Security Agency, to ensure the effective implementation of this advice. This includes work to ensure vaccine uptake of any implemented programmes is high. Numerous methods are used to ensure high uptake, including targeted communications, ensuring vaccine accessibility and availability.</p> answering member printed Lord Markham question first answered 05/04/2024 13:26:04 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1698294

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory Syncytial Virus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government how they plan to assess the wider productivity and economic benefits of any new immunisation programmes for infant respiratory syncytial virus.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL3598
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The independent Joint Committee for Vaccination and Immunisation (JCVI) advises the Department on the approach to vaccination and immunisation. The JCVI’s evaluation of the cost-effectiveness of a respiratory syncytial virus (RSV) programme was based on the health benefits of an infant RSV programme, and the potential healthcare cost savings from preventing cases and hospitalisations.</p><p>The Department did not ask the JCVI to complete an assessment of the wider productivity and economic benefits when determining the cost-effectiveness of a vaccination programme, and the Department did not assess this separately for RSV.</p> answering member printed Lord Markham question first answered 05/04/2024 13:33:43 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1698295

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory Syncytial Virus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government how they plan to assess the impact of new immunisation programmes for infant respiratory syncytial virus on (1) hospitalisations, and (2) health inequality.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL3599
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>The UK Health Security Agency (UKHSA) monitors national immunisation programmes in England. The UKHSA’s Severe Acute Respiratory Infection Watch surveillance system collects weekly information on admissions to hospital with Respiratory Syncytial Virus (RSV), to monitor admission rates in each RSV season. If a programme is introduced, monitoring of its effectiveness would include thorough analysis of immunisation records, both infant or maternal, and laboratory results for patients needing healthcare for RSV-like illness. The UKHSA can also monitor RSV admissions by deprivation and ethnicity, using routine National Health Service records, when these become available following the RSV season. The UKHSA will also monitor inequalities in uptake of the RSV immunisation programmes, through its routine uptake data collections.</p> answering member printed Lord Markham question first answered 05/04/2024 13:33:24 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick

1698222

	registered interest
	date	22/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Data Protection
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what steps they have taken to ensure that patient records and personal data are only accessible to those who need to view them, and to ensure connections between software systems in health facilities include suitable control measures for this risk.
	tabling member printed	Baroness Manzoor
	uin	HL3563
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>National IT systems must ensure that users can be identified correctly, and are given appropriate access. This is achieved using identity verification capabilities, including creating a national digital identity for each authorised user.</p><p> </p><p>Each local National Health Service organisation which requires access to the national IT systems is required to set up its own local Registration Authority (RA) which consists of people and processes who are trained to create identities and grant access for their staff to the national IT systems. NHS England has published the RA Policy requirements with which every local NHS organisation that has an RA must comply. This reflects current best practice for identity and access management as informed by the National Cyber Security Centre (NCSC) guidance.</p><p> </p><p>The RA Policy also allows non-NHS health and care organisations providing direct care to run their own RA service. RA hosting is subject to meeting requirements and assessment criteria, which are soon to be published.</p><p> </p><p>The RA process includes the use of RA codes, assigned to professional users’ smartcards to give them access to the correct information within national IT systems.</p><p> </p><p>The RA codes which are assigned for a specific user will allow that user to create and process referrals appropriately depending on their job role.</p><p> </p><p>Local organisations which have an RA function are required to have an RA audit policy and conduct annual audits on NHS Smartcard usage as part of their RA governance. RA Managers (those responsible for administering the RA function within an organisation) must implement a process to run the RA reports on a regular basis.</p> answering member printed Lord Markham question first answered 05/04/2024 13:25:38 answering member 4948 label Biography information for Lord Markham
	tabling member	4289 label Biography information for Baroness Manzoor

1698224

	registered interest
	date	22/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respiratory Syncytial Virus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what information they have on countries currently implementing immunisation programmes for infant respiratory syncytial virus with regard to (1) acceptance and uptake, and (2) hospitalisations.
	tabling member printed	Baroness Ritchie of Downpatrick
	uin	HL3565
	answer	answer is ministerial correction date of answer 05/04/2024 answer text <p>In the United States, as of 31 January 2024, maternal immunisation was 17.9%. By February 2024, 43% of infants under eight months old had received a dose of nirsevimab.</p><p>In Galicia, Spain, 92.9% of 5,357 infants born from 25 September 2023 to 4 February 2024 had nirsevimab, as well as 79.7% of 5,823 infants included in a catch-up programme. The peak of the hospitalisation rate in infants under six months old was 102 per 100,000 in 2023/24, during the week starting 27 November 2023. This is compared to a median of 776 for 2017/18, 2018/19 and 2019/20, peaking during the first week of the January.</p><p>In Luxembourg, 84% of 1524 infants born in hospital between early October and mid-December 2023 received nirsevimab. Luxembourg observed a decrease in hospitalisation in infants under six months old of 69%, between the 2022/23 and 2023/24 respiratory syncytial virus seasons.</p> answering member printed Lord Markham question first answered 05/04/2024 13:05:32 answering member 4948 label Biography information for Lord Markham
	tabling member	4130 label Biography information for Baroness Ritchie of Downpatrick